Peering into the future, has anyone considered the impact of LL on single-payer health systems, such as Canada, UK, Japan, etc. I would think once the LL cat is out of the bag, these countries will jump on our little therapeutic like flies on ape*^&$! What a savings for those countries and their health organizations.